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Cardiac outﬂow tractSignaling of bone morphogenetic protein (BMP) via type I and type II receptors is involved in multiple
processes contributing to cardiogenesis. To investigate the role of the BMP type II receptor (BMPRII) in
heart development, the BMPRII gene was deleted throughout the embryo during gastrulation using a
Mox2-Cre transgene. BMPRIIﬂox/−;Mox2-Cre mice exhibited cardiac defects including double-outlet right
ventricle, ventricular septal defect (VSD), atrioventricular (AV) cushion defects, and thickened valve
leaﬂets. To characterize the tissue-speciﬁc functions of BMPRII in cardiogenesis, a series of Cre transgenes
(αMHC-, Tie2-, Wnt1-, and SM22α-Cre) was employed. Interestingly, myocardial development was normal
when the BMPRII gene was deleted in myocardial cells using Mox2-Cre, αMHC-Cre, or SM22α-Cre
transgenes, suggesting that signaling by other BMP type II receptors may compensate for the absence of
BMPRII in the myocardial cells. AV cushion defects including atrial septal defect, membranous VSD, and
thickened valve leaﬂets were found in BMPRIIﬂox/−;Tie2-Cre mice. Abnormal positioning of the aorta was
observed in BMPRIIﬂox/−;Wnt1-Cre and BMPRIIﬂox/−;SM22α-Cre mice. Taken together, these results
demonstrate that endocardial BMPRII expression is required for septal formation and valvulogenesis.
Moreover, mesenchymal BMPRII expression in the outﬂow tract cushion is required for proper positioning
of the aorta.© 2009 Elsevier Inc. All rights reserved.Introduction
Congenital heart defects (CHDs) occur in approximately 1% of live
births and are the most common birth defects (Hoffman and Kaplan,
2002). Most CHDs are caused by abnormalities in septation and
valvulogenesis. Endocardial–mesenchymal transformation (EMT) is a
critical process for normal septation of the outﬂow tract (OFT) and
atrioventricular (AV) canal. In EMT, endocardial cells invade into the
cardiac jelly between the endocardium and myocardium and become
mesenchymal cells, subsequently contributing to the formation of
septa and valves (de Lange et al., 2004). Neural crest-derived cells
migrate into the cardiac OFT and differentiate into smooth muscle
cells (SMCs) of the great vessels and mesenchymal cells, which
contribute to the septation of OFT and formation of semilunar valves.
In addition, cells derived from the secondary heart ﬁeld play a criticall Care Research, Massachusetts
reet, Boston, MA 02114, USA.
axoSmithKline, King of Prussia,
l rights reserved.role in the orientation and patterning of the cardiac outﬂow tract
(Zhou et al., 2007). The tubular OFT rotates counterclockwise during
the formation of the great arteries (Bajolle et al., 2006). Failure of
rotation of the OFT can lead to abnormal positioning of the aorta and
pulmonary artery (PA).
Transforming growth factor (TGF)-β and bone morphogenetic
proteins (BMPs) are known to play important roles in cardiogenesis
(Bartram et al., 2001; Chen et al., 2004). BMPs bind to two different
serine/threonine kinase receptors (type I and type II), both of which
are required for signaling (Miyazono et al., 2005). BMPs signal via
three type I receptors (i.e., activin receptor-like kinase (ALK) 2, 3, and
6) and three type II receptors (i.e., BMP type II receptor (BMPRII),
activin type IIA receptor (ActRIIA), and activin type IIB receptor
(ActRIIB)). Activated type I receptors phosphorylate Smads 1, 5, and 8
to transduce BMP signals into the nucleus (Miyazono et al., 2005).
Since conventional gene targeting for most of the BMP receptors
causes early embryonic lethality (Beppu et al., 2000; Gu et al., 1999;
Mishina et al., 1995, 1999), conditional gene-targeting techniques
have been employed to identify the roles of BMP signaling in
cardiogenesis during mid-to-late gestation. For example, BMP4 is
expressed in the myocardium of the OFT during cardiogenesis.
Myocardium-speciﬁc deletion of the BMP4 gene using cardiac
168 H. Beppu et al. / Developmental Biology 331 (2009) 167–175troponin T-Cre results in double-outlet right ventricle (DORV) and
AV cushion defects (Jiao et al., 2003). Cardiac myocyte-speciﬁc
deletion of the ALK3 gene using α-myosin heavy chain (αMHC)-Cre
causes defects in the development of trabeculae, compact myocar-
dium, and endocardial cushion (Gaussin et al., 2002). The
endocardial cushion defect was associated with a decreased
expression of TGF-β2 in cardiac myocytes. Endocardial deletion of
ALK2 or ALK3 has shown that BMP signals are required for EMT and
the subsequent development of the AV cushion (Ma et al., 2005;
Song et al., 2007; Wang et al., 2005). BMP signaling is also required
for the development of cardiac OFT and great arteries: tissue-
speciﬁc deletion of ALK2 or ALK3 using Wnt1-Cre causes persistent
truncus arteriosus (PTA) due to the defect of OFT septation
(Kaartinen et al., 2004; Stottmann et al., 2004).
Mice homozygous for a BMPRII null mutation die during gastrula-
tion without forming mesoderm (Beppu et al., 2000). Mice homo-
zygous for a BMPRII hypomorphic allele, which has residual BMP
signaling activity, die at mid-gestation and exhibit skeletal and
cardiovascular abnormalities including PTA, interrupted aortic arch,
and absent semilunar valve formation (Delot et al., 2003).
To evaluate the impact of BMPRII deﬁciency on cardiogenesis,
BMPRII conditional knockout mice were generated using the Cre-
loxP system (Beppu et al., 2005). A series of Cre transgenes was
used to achieve epiblast-speciﬁc gene deletion during gastrulation
or tissue-speciﬁc gene deletion. We report that BMPRII deﬁciency,
when induced throughout the embryo using Mox2-Cre (Tallquist
and Soriano, 2000), causes severe cardiac defects including DORV,
ventricular septal defect (VSD), and abnormal AV cushion remodel-
ing. AV cushion defects (membranous VSD, atrial septal defect
(ASD), and thickened valves) were also detected in mice with
endocardium-speciﬁc BMPRII deﬁciency. Abnormal positioning of
the aorta was observed following deletion of the BMPRII gene with
either Wnt1-Cre or SM22α-Cre, indicating that mesenchymal
BMPRII in the OFT cushion is required for the appropriate rotation
and/or positioning of the OFT. Taken together, these ﬁndings
suggest that BMPRII has critical roles in both OFT and AV cushion
development.Fig. 1. BMPRII deletion by the Mox2-Cre transgene causes perinatal lethality. (A) Mox2-Cre
ROSA26 reporter allele. At E9.5, gene recombinationwas detected throughout the embryo (bl
used as a negative control (embryo on the left). (B) The breeding strategy used to obtain them
as control mice. (C) Photographs of control and mutant embryos at E16.5 are shown. One o
(middle and right). Scale bars: 1 mm (A) and 5 mm (C).Materials and methods
Mice
Mice carrying a BMPRII allele in which exons 4 and 5 are ﬂanked
by loxP sequences were generated previously (Beppu et al., 2005).
Mox2-, Tie2-, and Wnt1-Cre transgenic mice and ROSA26 reporter
(R26R) mice were purchased from the Jackson Laboratory (Bar
Harbor, ME, USA). αMHC-Cre mice were obtained from Dr. Abel
(Abel et al., 1999). SM22α-Cre mice were generated as described
previously (Lepore et al., 2005). All control and mutant mice used in
this study carried one copy of the R26R transgene. Experiments
using animals were approved by the Massachusetts General Hospital
Subcommittee on Research Animal Care.
Measuring BMPRII gene expression
Total RNA was extracted from embryonic hearts at E14.5 using
TRIzol reagent (Invitrogen), and cDNAwas synthesized by the reverse
transcriptase reaction. Primer sequences for BMPRII exons 4 and 5
were described previously (Yu et al., 2005).
Morphology
Cardiac or embryonic tissues were ﬁxed in 4% paraformaldehyde
(PFA) in phosphate-buffered saline (PBS) at 4 °C overnight, embedded
in parafﬁn, and sectioned at 6-μm thickness. Sections were stained
with hematoxylin and eosin. Staining for β-galactosidase activity was
performed as described previously (Beppu et al., 2008).
Measuring DNA synthesis
BrdU (bromodeoxyuridine) was injected intraperitoneally into
pregnant females (100 μg/gram of body weight) at E16.5. The females
were sacriﬁced 4 h after injection, and the embryos were ﬁxed in 4%
PFA, embedded in parafﬁn, and sectioned at 6-μm thickness. The
sections were incubated with anti-BrdU antibodies conjugated with-mediated recombination was detected by staining for β-galactosidase activity using a
ue staining in the embryo on the right). An embryowithout theMox2-Cre transgenewas
utant mice is shown. The three genotypes other than BMPRIIﬂox/−;Mox2-Crewere used
f the three mutant mice was alive (left), but other two were found to be dead in utero
Table 1
Number of embryos obtained from crosses between BMPRII+/−;Mox2-Cre mice and
BMPRIIﬂox/ﬂox mice.
BMPRIIﬂox/+;
Cre−
BMPRIIﬂox/−;
Cre−
BMPRIIﬂox/+;
Cre+
BMPRIIﬂox/−;
Cre+
E9.5–12.5 77 82 75 78
E13.5–16.5 43 50 49 27⁎
E17.5–18.5 17 13 10 3⁎
P1–2 13 19 14 2⁎
The number of live embryos recovered from various developmental stages is shown.
⁎ Pb0.01 compared with the expected Mendelian ratio.
169H. Beppu et al. / Developmental Biology 331 (2009) 167–175horseradish peroxidase (Roche Applied Science, IN). Binding of the
antibodies was visualized with Tyramide Signal Ampliﬁcation kit
(Perkin Elmer Life and Analytical Sciences, MA) and 3,3′-diamino-
benzidine (DAB Substrate Kit, Vector Laboratories, CA). The sections
were counterstained with hematoxylin. DNA synthesis was reﬂected
in the percentage of cell nuclei which were stained with anti-BrdU
antibody. The DNA-binding dye Hoechst H33258 was used to count
the number of dividing cells in semilunar valves at E17.5–18.5, as a
quantitative index of the cell proliferation.
Immunohistochemistry
Tissue sections from mouse embryos were reacted with primary
antibodies, including phospho-Smad1/5/8 antibodies (Cell Signaling
Technology, MA) and NFATc1 antibodies (BD Biosciences, CA). Bound
primary antibodies were detected using biotinylated secondary
antibodies with Fluorescein-Avidin D (Vector Laboratories) for
phospho-Smad1/5/8 or Vectastain Elite ABC kit with DAB (Vector
Laboratories) for NFATc1.
Results
BMPRII deletion in the epiblast causes perinatal lethality
The BMPRII conditional mutant allele was previously generated
using Cre-loxP system, inwhich a genomic fragment containing exons
4 and 5 of the BMPRII gene was ﬂanked by two loxP sites (Beppu et al.,
2005). Deletion of the BMPRII gene in the epiblast during gastrulation
was performed at as early as embryonic day (E) 5 using a Mox2-Cre
transgene (Tallquist and Soriano, 2000). Using this approach, the
BMPRII gene was disrupted in all of the embryonic tissues during orFig. 2. Outﬂow tract defects in BMPRIIﬂox/−;Mox2-Cre mice at E12.5–14.5. (A, B) Photogra
pulmonary artery. (C, D) Staining for β-galactosidase activity was performed to detect gene r
at E12.5. (E, F) Hematoxylin and eosin staining of the embryonic hearts from control (E) and
(F). (G) Schematic diagram of the “ﬂoxed” allele and the deleted allele with loxP sites (ﬁlled t
and 5 (arrows). Ethidium bromide staining of PCR products for the BMPRII gene expressionafter the gastrulation stage, but not in some extra-embryonic tissues
including the primitive endoderm. Cell lineages in which the
transgene was expressed were identiﬁed by staining for β-
galactosidase activity, which is expressed when the ROSA26 reporter
(R26R) allele undergoes Cre-mediated recombination. Gene recom-
bination activity of Mox2-Cre in the entire embryo was conﬁrmed at
E 9.5 (Fig. 1A). BMPRII heterozygous mutant (BMPRII+/−) male
mice carrying the Mox2-Cre transgene were crossed with female
mice homozygous for a BMPRII conditional mutant (“ﬂoxed”) allele
(BMPRIIﬂox/ﬂox) and the R26R allele (Fig. 1B). BMPRIIﬂox/−;Mox2-Cre
mice and control mice were examined at various embryonic stages
and after birth. The numbers of live embryos for each genotype are
shown in Table 1. The BMPRIIﬂox/−;Mox2-Cre embryos were
observed in the anticipated Mendelian ratios through E12.5.
However, there were only two BMPRIIﬂox/−;Mox2-Cre mice among
48 live littermates recovered after birth at postnatal day (P) 2. Some
BMPRIIﬂox/−;Mox2-Cre embryos were found to be dead at E16.5
with varying degrees of resorption, whereas other BMPRIIﬂox/−;
Mox2-Cre mutant embryos remained normal in gross appearance
(Fig. 1C).
Global deletion of BMPRII with Mox2-Cre causes cardiac defects in the
outﬂow tract and AV canal
While only a fraction of the BMPRIIﬂox/−;Mox2-Cre embryos
survived to late gestation without obvious growth retardation, all of
the embryos showed cardiac defects including DORV with a VSD.
DORV was observed as early as E12.5 (Figs. 2B, D), whereas the OFT
developed normally in control mice (Figs. 2A, C). At E12.5, Cre
recombinase activity was observed throughout the cardiac tissues in
both control (BMPRIIﬂox/+;Mox2-Cre) and mutant (BMPRIIﬂox/−;
Mox2-Cre) embryos (Figs. 2C, D). At E14.5, sections of developing
hearts at the level of the PA showed persistent DORV in the
BMPRIIﬂox/−;Mox2-Cre embryos (Fig. 2F) in contrast to the control
hearts (Fig. 2E). Septation between the ascending aorta and PA
occurred normally in the mutant heart (Fig. 2F). At E14.5, mRNA
containing exons 4 and 5 of BMPRII (Fig. 2G) was detected in
control, but not in the BMPRIIﬂox/−;Mox2-Cre mutant hearts using
the reverse transcription-polymerase chain reaction (RT-PCR).
Normal development of the OFT and AV canal is complete by E16.5;
however, persistent DORV and AV canal defects were observed in
BMPRIIﬂox/−;Mox2-Cre mutant hearts at this stage (Fig. 3). The OFT of
a control heart is shown at the level of the pulmonary valve (Fig. 3A)phs of embryonic hearts from control (A) and mutant (B) mice at E12.5. Ao: aorta, P:
ecombination on the frozen sections of the hearts from control (C) andmutant (D) mice
mutant (F) mice at E14.5. DORVwas observed in the mutant hearts at E12.5 (D) and 14.5
riangles). BMPRII gene expressionwas detected by RT-PCR using a primer set for exons 4
was shown for control and mutant (n=2 for each). Scale bars: 0.5 mm (A–F).
Fig. 3.Defects of the outﬂow tract and AV canal in BMPRIIﬂox/−;Mox2-Cremice. Hematoxylin and eosin staining is shown for control (A–D) andmutant (E–H)mice at E16.5. DORV (E,
F), VSD (F, arrow), and AV canal defect with abnormal atrial septation (G, H) were observed in BMPRIIﬂox/−;Mox2-Cre mice. Ao: aorta, P: pulmonary artery, LA: left atrium, RA: right
atrium, LV: left ventricle, RV: right ventricle. Scale bars: 0.5 mm (A–H).
170 H. Beppu et al. / Developmental Biology 331 (2009) 167–175and aortic valve at E16.5 (Fig. 3B). In the BMPRIIﬂox/−;Mox2-Cre
mutant heart, DORV (Figs. 3E, F) with a VSD (Fig. 3F, arrow) was
observed. The tricuspid valve (TV) and mitral valve (MV) of a control
heart are shown in Figs. 3C, D. In contrast, in BMPRIIﬂox/−;Mox2-Cre
mutants the right atriumwas shifted leftward (Figs. 3G, H), and atrial
septal formationwas disrupted (Fig. 3H). Aside from a VSD, therewere
no obvious structural defects in the myocardium in BMPRIIﬂox/−;
Mox2-Cre mutant embryos (Fig. 3). The great arteries and the aortic
arch in BMPRIIﬂox/−;Mox2-Cre embryos appeared normal when
examined by India ink injection at E14.5 (data not shown).
Quantitative RT-PCR revealed that expression of genes encoding
cardiac transcription factors including Nkx2.5, MEF2C, GATA4, Tbx2,
Tbx3, Tbx5, and dHand did not differ in control and BMPRIIﬂox/−;
Mox2-Cre mutant hearts at E10.5 (data not shown).
Normal initiation of AV cushion formation and cell proliferation in
BMPRII mutant embryos
Histological analysis revealed that EMT occurred and progressed
normally in the AV cushion of the BMPRIIﬂox/−;Mox2-Cre embryos at
E11.5 (Figs. 4A, B). Mesenchymal cells transformed from endocardial
cells were stained for phospho-Smad1/5/8 to detect active BMP
signaling in the AV cushion (Figs. 4C, D). Smad1/5/8 phosphorylation
was detected in the absence of BMPRII (Fig. 4D), suggesting that BMP
signaling is transduced via alternate BMP type II receptors (i.e., ActivinFig. 4. AV cushion development and cardiac cell proliferation in BMPRIIﬂox/−;Mox2-Cre m
Sections of the AV cushion at E11.5 were stained with hematoxylin and eosin. (C, D) Sections s
and 8 (green) and counterstained with propidium iodide (red). (E, F) Immunohistostaining f
was performed to detect proliferating cardiac cells (brown nuclei) at E16.5. Scale bars: 0.1 mtype IIA or IIB receptors). At E9.5, NFATc1 is known to regulate the
initiation of EMT. However, no difference in NFATc1 expression
between control and BMPRIIﬂox/−;Mox2-Cre mutant embryos was
observed (Figs. 4E, F). Labeling of proliferating cells with BrdU
revealed a similar number of cardiac cells undergoing DNA synthesis
in both control and BMPRIIﬂox/−;Mox2-Cre mutant embryos (Figs. 4G,
H). The fraction of cells that are actively synthesizing DNA (BrdU-
positive) did not differ in control and mutant hearts (35±3% (n=2)
versus 34±1% (n=3), respectively).
Endocardial BMPRII is required for remodeling of the AV cushion
To determine the role of BMPRII in endocardial cell regulation of
AV cushion and valve formation, the BMPRII gene was deleted
speciﬁcally in the endocardial cell lineage using a Tie2-Cre
transgene. The majority of BMPRIIﬂox/−;Tie2-Cre mice died within
one week after birth. In mice carrying the Tie2-Cre transgene, Cre-
mediated recombination occurs in endocardial cells at E9.5 (de
Lange et al., 2004), many of which subsequently transform into
mesenchymal cells and contribute to the formation of AV cushion
and valves (semilunar and AV). The membranous portion of the
interventricular septum (IVS) was stained for β-galactosidase
activity from the R26R allele in BMPRIIﬂox/+;Tie2-Cre control mice
at P2 (Fig. 5A, arrow). In BMPRIIﬂox/−;Tie2-Cre mutant mice,
however, the membranous portion of the IVS failed to connect toice. Cardiac tissues from control (A, C, E, G) and mutant (B, D, F, H) are shown. (A, B)
hown in A and Bwere reactedwith antibody directed against phosphorylated Smads1, 5,
or NFATc1 (brown) at E9.5 is shown. AVC: AV cushion. (G, H) BrdU incorporation for 4 h
m (A–F) and 0.5 mm (G, H).
Fig. 5. BMPRII deletion in endocardial lineage cells using a Tie2-Cre transgene. (A, B) Staining for β-galactosidase activity (blue) with nuclear fast red counterstaining (pink) was
performed at P2. Tie2-Cre activity was detected in themembranous portion of the interventricular septum in control mice (A, arrow). In BMPRIIﬂox/−;Tie2-Cremutant mice at P2, the
membranous portion of the septum failed to connect to the muscular portion of the septum (B, arrow). Mitral valve leaﬂets stained positively for β-galactosidase activity (B).
Hematoxylin and eosin staining of a mitral valve from a control mouse (C) and a BMPRIIﬂox/−;Tie2-Cre mutant mouse (D) at P2 is shown. RV: right ventricle, LV: left ventricle, IVS:
interventricular septum, Ao: aorta, LA, left atrium, MV: mitral valve. Scale bars: 0.2 mm (A, B) and 0.1 mm (C, D).
171H. Beppu et al. / Developmental Biology 331 (2009) 167–175the muscular portion of the IVS (Fig. 5B, arrow). Expression of β-
galactosidase from the R26R allele was detected in both tricuspid
(data not shown) and mitral valves (Fig. 5B). The mitral valve
leaﬂets were signiﬁcantly thickened in the BMPRIIﬂox/−;Tie2-Cre
mutant mice (Fig. 5D) compared to those in control mice (Fig. 5C).
Similar ﬁndings were found in the tricuspid valves of BMPRIIﬂox/−;
Tie2-Cre mutant mice (data not shown). These results indicate that
BMPRII deletion in the endocardial cell lineage does not block the
initiation of EMT, but does lead to abnormal remodeling of the AV
cushion forming the ventricular septum and aberrant formation of
the tricuspid and mitral valves.Fig. 6. Thickened semilunar valves in BMPRIIﬂox/−;Mox2-Cre and BMPRIIﬂox/−;Tie2-Cre
mice. (A–D) Hematoxylin and eosin staining is shown for the aortic valve in a control
mouse at E17.5 (A), for aortic and pulmonary valves with DORV in a BMPRIIﬂox/−;Mox2-
Cre mouse at E17.5 (B), for a pulmonary valve in a control mouse at P3 (C), and for a
pulmonary valve in a BMPRIIﬂox/−;Tie2-Cre mouse (D). AoV: aortic valve, PV:
pulmonary valve. Scale bars: 0.2 mm (A–D).BMPRII deletion causes thickened semilunar valve formation
During late embryonic and postnatal development, valve leaﬂets
elongate and remodel to form mature valve leaﬂets (Hinton et al.,
2006). Normal aortic (E17.5) and pulmonary (P3) valves are shown in
Figs. 6A and C, respectively. BMPRIIﬂox/−;Mox2-Cre mutant mice
(E17.5; Fig. 6B) and BMPRIIﬂox/−;Tie2-Cre mutant mice (P3; Fig. 6D)
have abnormally-thickened semilunar valves as compared to control
littermates. The thickening of semilunar valveswas obvious after E16.5Fig. 7. Overriding aorta in BMPRIIﬂox/−;SM22α-Cre and BMPRIIﬂox/−;Wnt1-Cre mice. (A–
D) Hematoxylin and eosin staining is shown for a control mouse (A) and a BMPRIIﬂox/−;
SM22α-Cre mouse (B) at E14.5, and a control mouse (C) and a BMPRIIﬂox/−;Wnt1-Cre
mouse (D) at P3. The OFT from the left ventricle was severely deviated to the right side of
the heart in the BMPRIIﬂox/−;SM22α-Cre mouse. The aortic valve is located over the right
ventricle (B, arrow) in this long axis cross section, whereas the aortic valve in a control
mouse is located centrally (A). An overriding aortawith a small VSD (D, arrow) is observed
in BMPRIIﬂox/−;Wnt1-Cre mice, whereas the normal position of the aorta is shown in
control mice at P3 (C). AoV: aortic valve. Scale bars: 0.5 mm (A–D).
Fig. 8. BMPRII deﬁciency interrupts normal rotation of the OFT in a tissue-speciﬁc manner. The normal rotation of the aorta (red) and the pulmonary artery (black) during cardiac
development is shown from a cranial view (upper panel) and a lateral view (middle panel). In this illustration of embryonic hearts (looping stage), BMPRII-deﬁcient cardiac tissues
are colored in blue for each Cre transgene (lower panel). Normal tissues (Cre-negative) are shown in pink (myocardium), red (endocardium), and brown (OFT and AV cushions). The
rotational process is interrupted at different stages for each Cre transgenic strain as shown in the diagrams. Note that neural crest-derived cells expressing Wnt1-Cre partially
contribute to the formation of the OFT cushion. Varying degrees of malrotation are observed with BMPRIIﬂox/−mice with the Mox2-Cre, SM22α-Cre, and Wnt1-Cre transgenes. The
severity of aortic malpositioning likely correlates with the number of BMPRII-deﬁcient mesenchymal cells in the OFT cushion and/or the timing of BMPRII deletion. Ao: aorta, P:
pulmonary artery, IFT: inﬂow tract, OFT: outﬂow tract.
172 H. Beppu et al. / Developmental Biology 331 (2009) 167–175in BMPRIIﬂox/−;Mox2-Cre mutant mice. At E17.5–18.5, the number of
dividing cells in the semilunar valves of BMPRIIﬂox/−;Mox2-Cre
mutant mice was greater than that of the control mice (1.4±0.2
versus 3.7±0.3 cells per section in control andmutant, respectively; 4
sections from each of 4mice in both genotypes, Pb0.05). There was no
difference in cell density or evidence of apoptosis (as measured using
TUNEL staining) in normal and thickened valve leaﬂets at E16.5
(Mox2-Cre) and P2 (Tie2-Cre) (data not shown).
Mesenchymal BMPRII in the OFT cushion regulates positioning of
outﬂow tract
The SM22α-Cre transgene is expressed in vascular and visceral
smooth muscle cells. During the development of murine embryos,
the SM22α-Cre transgene is also expressed in all cardiac tissues
except for endocardial cells (Lepore et al., 2005). The majority of
BMPRIIﬂox/−;SM22α-Cre mice died shortly after birth. Abnormal
positioning of the OFT (Fig. 7B, arrow) and VSDs (data not shown)
were observed in the BMPRIIﬂox/−;SM22α-Cre mice at E14.5. In the
control heart at E14.5 (Fig. 7A), the OFT from the left ventricle
(LV) to the ascending aorta is positioned nearly vertically above
the LV outﬂow tract and the IVS. In the mutant heart, the OFT
deviates rightward, resulting in abnormal positioning of the aortic
valve and ascending aorta (Fig. 7B). These results indicate that
deletion of BMPRII in the OFT cushion causes the rotation of the
OFT to be stopped prematurely after formation of the aorto-
pulmonary septum (Fig. 8).
Neural crest-derived cells migrate to great arteries and to the
cardiac OFT. The cells populate the truncus arteriosus at E9.5 and
invade into OFT cushions at E10.5 (Jiang et al., 2000). To determine
whether the observed OFT patterning defect results from abnormal-
ities in neural crest-derived SMCs and mesenchymal cells populating
the OFT, the BMPRII gene was deleted in neural crest-derived cells
using a Wnt1-Cre transgene. An overriding aorta and small VSD (Fig.
7D, arrow) were observed in BMPRIIﬂox/−;Wnt1-Cre mice, and the
rightward deviation of the OFT was less severe than that of the
BMPRIIﬂox/−;SM22α-Cremice (Figs. 7B–D). Of note, the positioning of
the OFT appeared to be normal in the BMPRIIﬂox/−;Tie2-Cre and
BMPRIIﬂox/−;αMHC-Cre mutant mice (data not shown). These resultssuggest that expression of BMPRII in neural crest-derived cells
contributes to normal positioning of the aorta.
BMPRII is not essential for normal myocardial development
Absence of obvious myocardial defects in BMPRIIﬂox/−;Mox2-Cre
mutant hearts suggested the possibility that BMPRII is not necessary
for the development of myocardial cells. To further test this
hypothesis, we examined the myocardium of BMPRII ﬂoxed mice
carrying the SM22α-Cre or αMHC-Cre transgene, both of which
express the Cre recombinase in myocardial cells during development.
There were no myocardial defects in the BMPRII ﬂoxed mice carrying
the SM22α-Cre (Fig. 7B) or αMHC-Cre transgene (data not shown).
BMPRIIﬂox/−;αMHC-Cre mutant mice had a normal life span.
Discussion
BMP signaling plays important roles in many aspects of cardiogen-
esis including endocardial cushion and valve maturation (Delot, 2003;
Schneider et al., 2003). Since BMPRII homozygous mutant embryos
die during gastrulation (Beppu et al., 2000), our knowledge of the role
of the BMPRII gene in the development of murine embryos during
mid-to-late gestation has been largely incomplete. In this study, we
examined the roles of BMPRII in cardiogenesis using a BMPRII
conditional mutant allele (Beppu et al., 2005). We demonstrate the
essential role of BMPRII in key aspects of cardiogenesis including the
regulation of OFT position, AV cushion remodeling, and valve
formation.
BMPRII is primarily required for cardiac development after gastrulation
To examine the role of the BMPRII gene in murine development
after the gastrulation stage, the Mox2-Cre transgene was employed to
delete the gene in epiblast cells during gastrulation (E5.5–7.5), but not
in extra-embryonic tissues such as primitive endoderm and extra-
embryonic ectoderm derivatives (Tallquist and Soriano, 2000).
Previous reports have suggested that Mox2-Cre-induced DNA recom-
bination is incomplete resulting in genetic mosaicism (Davis et al.,
2004). However, we found that expression of the BMPRII gene was
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2G) in the cardiac tissues of the mutant embryos. After deletion of the
BMPRII gene in the epiblast cells at around E6.5, BMPRIIﬂox/−;Mox2-
Cre embryos continued to develop through E16.5. The most obvious
phenotypes observed in BMPRIIﬂox/−;Mox2-Cre embryos were car-
diac defects, including DORV, VSD, abnormal AV cushion remodeling,
and thickened valve leaﬂets. These results suggest that BMPRII is
required for development of extra-embryonic tissues during gas-
trulation and for cardiac development after the gastrulation stage.
The phenotypes observed in BMPRIIﬂox/−;Mox2-Cre embryos appear
to be less severe than those observed in embryos in which the ALK3
gene was deleted using the same Mox2-Cre transgene (Davis et al.,
2004). The ALK3 mutant embryos exhibited defects in endodermal
morphogenesis and ectodermal patterning and died around E10.5
(Davis et al., 2004). Although BMP signaling is required for many
developmental processes, most of the embryonic organs other than
the heart appear to develop normally in the BMPRIIﬂox/−;Mox2-Cre
embryos. Since both type I and type II receptors are required for
BMP signaling (Kawabata et al., 1998), other BMP type II receptors
(i.e., ActRIIA or ActRIIB) may partially compensate for loss of
BMPRII. We previously reported the ability of ActRIIA to substitute,
in part, for BMPRII for the activation of the Smad pathway in murine
pulmonary artery smooth muscle cells (Yu et al., 2005). The
gastrulation defects in the BMPRII−/− embryos and/or cardiac
defects in BMPRIIﬂox/−;Mox2-Cre embryos may occur in tissues
where the other type II receptors for BMPs are not available to
compensate for the function of BMPRII. Alternatively, BMP ligand-
speciﬁc gain of function in BMPRII-deﬁcient cardiac cells, similar to
that which we observed in pulmonary artery smooth muscle cells
(Yu et al., 2005), could contribute to the defects observed in
embryos deﬁcient in BMPRII. However, we cannot exclude the
possibility that the cardiac defects observed in the BMPRIIﬂox/−;
Mox2-Cre embryos are a result of disrupted non-Smad pathways,
including molecules which may directly interact with BMPRII (Chan
et al., 2007; Foletta et al., 2003; Hassel et al., 2004; Machado et al.,
2003).
BMPRII is not necessary for myocardial development
BMPs play important roles in myocardial development. Myo-
cardium-speciﬁc deletion of ALK3 using the αMHC-Cre transgene
showed that ALK3 is required for normal development of
trabeculae, compact myocardium, interventricular septum, and
endocardial cushion (Gaussin et al., 2002). However, the develop-
ment of myocardium seems to be unaffected in the BMPRIIﬂox/−;
Mox2-Cre embryos, in which the BMPRII gene was deleted in
epiblast cells before the initiation of cardiac development. Levels of
mRNA encoding Nkx2.5, GATA4, Tbx2, Tbx3, Tbx5, Mef2c, and
dHand in BMPRIIﬂox/−;Mox2-Cre hearts did not differ from those in
control hearts at E10.5 (data not shown). Furthermore, there were
no obvious myocardial defects in BMPRIIﬂox/−;αMHC-Cre nor
BMPRIIﬂox/−;SM22α-Cre mice, in which Cre recombinase is
expressed in the myocardium. Together, these results suggest that
BMPRII is dispensable for the development of myocardium and that
BMP signaling in myocardial cells may be transduced via ActRIIA or
ActRIIB in the absence of BMPRII.
BMPRII is required for remodeling of AV cushion
Formation of endocardial cushions is one of the key events in
cardiogenesis. ALK2 and ALK3 regulate the initiation of EMT, and
endocardial-speciﬁc deletion of ALK2 or ALK3 blocks the initiation of
EMT with few, if any, mesenchymal cells observed in the AV cushions
(Song et al., 2007; Wang et al., 2005). However, in the AV cushion of
BMPRIIﬂox/−;Mox2-Cre mutant embryos, initiation of EMT appears to
be normal, and comparable levels of Smad1/5/8 phosphorylationwere detected in the AV cushions of mutant and control embryos
(Fig. 4). Similarly, the progression of EMT seemed to be normal in
BMPRIIﬂox/−;Tie2-Cre embryos, but deletion of the BMPRII gene
speciﬁcally in endocardial cells results in a membranous VSD (Fig. 5B,
arrow). These results suggest that BMPRII is required for AV cushion
remodeling to form an intact interventricular septum.
Tissue-speciﬁc deﬁciency of BMPRII causes muscular or membranous
VSDs
Presence of a muscular VSDwas associated with abnormal rotation
of the OFT, such as DORV (BMPRIIﬂox/−;Mox2-Cre) and severely
overriding aorta (BMPRIIﬂox/−;SM22α-Cre), raising the possibility
that muscular VSD formation was “secondary” to abnormal OFT
rotation. Absence of a VSD in BMPRIIﬂox/−;αMHC-Cre mutant mice
also suggests that BMPRII deﬁciency in cardiac myocytes is insufﬁcient
to induce VSD formation.
The location of the membranous VSD in BMPRIIﬂox/−;Tie2-Cre
and BMPRIIﬂox/−;Wnt1-Cre mutant mice correlates with the
expression of the Cre recombinase transgene in the IFT and OFT
cushions. These results suggest a role for BMPRII in the maturation
of endocardial cushions, and speciﬁcally, the membranous portion of
the IVS.
BMPRII deﬁciency causes thickening of valve leaﬂets
BMP signaling is known to regulate cardiac valvulogenesis
(Armstrong and Bischoff, 2004). In late gestation, valve remodeling
begins and continues into postnatal life to form mature valve
leaﬂets (Hinton et al., 2006). Valvular cell proliferation is drama-
tically decreased during the remodeling stage (Hinton et al., 2006).
We found that BMPRII deﬁciency causes thickening of valve leaﬂets
(Figs. 5D and 6), which was most evident after E16.5. We observed
that the number of dividing cells in the thickened semilunar valves
of BMPRIIﬂox/−;Mox2-Cre mutant mice was greater than that of
control mice at E17.5–18.5. In contrast, there were no detectable
apoptotic cells in the control and mutant valves. Moreover, there
was no difference in the valve cell density between the two
genotypes (data not shown). These results suggest that BMPRII
deﬁciency leads to increased and/or persistent proliferation of
mesenchymal cells, resulting in the development of thickened
semilunar valve leaﬂets.
Delot et al. reported mice homozygous for a truncated BMPRII
mutation, which die at mid-gestation with various defects, including
skeletal abnormalities, PTA, and an interrupted aortic arch (Delot et
al., 2003). The truncated BMPRII (expressed from the mutant allele)
has reduced BMP signaling capacity compared with wild-type
BMPRII. In contrast to our ﬁndings, semilunar valves did not form
in mice homozygous for the truncated BMPRII. On the other hand,
mice with augmented BMP signaling due to deﬁciency of Smad6 or
Noggin, which act as endogenous inhibitors of BMP signaling, also
had thickened heart valves (Choi et al., 2007; Galvin et al., 2000).
These results suggest that thickened valve leaﬂets observed in the
BMPRIIﬂox/−;Mox2-Cre embryos and BMPRIIﬂox/−;Tie2-Cre mice
may be due to augmented BMP signaling in the BMPRII-deﬁcient
cells (Yu et al., 2005). It is possible that presence of a truncated
BMPRII could interfere with components of BMP signaling pathways
(i.e., through sequestration of type I BMP receptors) resulting in
more severe phenotypes than the complete absence of BMPRII, for
which ActRIIA or ActRIIB may compensate. However, we cannot
exclude the possibility that the different gene-targeting strategies
(which lead to the expression of truncated BMPRII from the
beginning of life in all cells including extra-embryonic tissues
versus induced BMPRII deﬁciency at certain developmental stages in
tissue-speciﬁc manner) contribute to the differing valve leaﬂet
phenotypes.
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Rotation of the OFT is critical for the proper positioning of
ascending aorta and pulmonary artery (Bajolle et al., 2006). Although
neural crest-derived cells are known to play a role in this process
(Restivo et al., 2006), the mechanisms by which the rotation is
initiated and regulated are largely unknown. Conditional deletion of
ALK2 or ALK3 using aWnt1-Cre transgene both cause severe defects in
the OFT with failure to septate the aorto-pulmonary trunk leading to
PTA (Kaartinen et al., 2004; Stottmann et al., 2004). Compared to
these phenotypes, the hearts in BMPRIIﬂox/−;Mox2-Cre embryos
showed normal aorto-pulmonary septation, but exhibited DORV.
This result suggests that BMPRII is required for the normal rotation of
the OFT and other type II BMP receptors are sufﬁcient for aorto-
pulmonary septation. Furthermore, tissue-speciﬁc deletion of the
BMPRII gene using Wnt1-Cre or SM22α-Cre also results in abnormal
positioning of the aorta (i.e., overriding aorta) with varying degrees of
severity. However, endocardial-speciﬁc deletion of BMPRII with a
Tie2-Cre transgene does not cause the abnormal positioning of the
ascending aorta likely because the Tie2-Cre transgene is expressed in
only a small fraction of the mesenchymal cells of the OFT cushion.
Deletion of the BMPRII gene using Mox2-, SM22α-, and Wnt1-Cre
interrupted the normal rotational process of the aorta and pulmonary
artery and resulted in the malpositioning of the aorta ranging from
DORV to overriding aorta (Fig. 8). BMPRIIﬂox/−;SM22α-Cre mutant
mice have more severe rightward deviation of the overriding aorta
than do BMPRIIﬂox/−;Wnt1-Cre mutant mice. The severity of the
abnormal positioning of the aorta may correlate with the fraction of
OFT mesenchymal cells in which the BMPRII gene is deleted and/or
the timing of the BMPRII deletion in the OFT cushion.
In summary, BMPRII deletion using conditional gene targeting
revealed various congenital defects including DORV, overriding aorta,
VSD, and thickened valve leaﬂets. Our results show that mesenchymal
BMPRII in the OFT cushion is responsible for the proper positioning of
the OFT. These ﬁndings further contribute to our understanding of the
tissue-speciﬁc role of BMPRII during cardiogenesis and may have
future clinical implications for patients with CHD and/or valvular
heart disease.
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